Now recruiting
Select your nearest location above for the full list of local trials, or scroll though the latest studies below.
This Phase 3, randomised, placebo-controlled, observer-blind clinical trial is designed to evaluate the safety, efficacy and immunogenicity of an investigational vaccine (mRNA-1647) for CMV in healthy volunteers.
This Phase 3, randomised, placebo-controlled, observer-blind clinical trial is designed to evaluate the safety, efficacy and immunogenicity of an investigational vaccine (mRNA-1647) for CMV in healthy volunteers.
This Phase 3, randomised, placebo-controlled, observer-blind clinical trial is designed to evaluate the safety, efficacy and immunogenicity of an investigational vaccine (mRNA-1647) for CMV in healthy volunteers.
This phase 2a study is testing the safety, immunogenicity and reactogenicity of concomitant administration of a new broad-spectrum influenza vaccine (OVX836) with quadrivalent inactivated influenza virus (QIV) vaccines in healthy volunteers.
This phase 2a study is testing the safety, immunogenicity and reactogenicity of concomitant administration of a new broad-spectrum influenza vaccine (OVX836) with quadrivalent inactivated influenza virus (QIV) vaccines in healthy volunteers.
This phase 2a study is testing the safety, immunogenicity and reactogenicity of concomitant administration of a new broad-spectrum influenza vaccine (OVX836) with quadrivalent inactivated influenza virus (QIV) vaccines in healthy volunteers.
A Randomised, Double-Blind, Placebo-Controlled, Parallel-Arm Study to Evaluate the Efficacy, Safety and Tolerability of 150 mg Sublingual Cannabidiol in Adults with Mild-to-Moderate Pain.
A Randomised, Double-Blind, Placebo-Controlled, Parallel-Arm Study to Evaluate the Efficacy, Safety and Tolerability of 150 mg Sublingual Cannabidiol in Adults with Mild-to-Moderate Pain.
A Randomised, Double-Blind, Placebo-Controlled, Parallel-Arm Study to Evaluate the Efficacy, Safety and Tolerability of 150 mg Sublingual Cannabidiol in Adults with Mild-to-Moderate Pain.
A Randomised, Double-Blind, Placebo-Controlled, Parallel-Arm Study to Evaluate the Efficacy, Safety and Tolerability of 150 mg Sublingual Cannabidiol in Adults with Mild-to-Moderate Pain.
This study aims to evaluate the immunogenicity and safety of ChulaCov19 BNA159 Vaccine as a Booster Dose.
This study aims to evaluate the immunogenicity and safety of ChulaCov19 BNA159 Vaccine as a Booster Dose.
This study aims to see if experimental drug, Xanamem™ is 'is effective in treating cognitive and depressive symptoms for people that have ongoing depression with cognitive symptoms.
Is Chronic knee Pain holding you back? If you're living with chronic knee pain and have not received lasting relief from medications, you may qualify for a new clinical research study. Apply now
Is Chronic knee Pain holding you back? If you're living with chronic knee pain and have not received lasting relief from medications, you may qualify for a new clinical research study. Apply now
Are you interested in participating in clinical trials?
We value your privacy and are committed to protecting your data and personal information.
